105655-17-2

Basic information

• Product Name: Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate
• Synonyms: 2-Bromo-4-(methoxycarbonyl)-6-nitroaniline, 2-Amino-3-bromo-5-(methoxycarbonyl)nitrobenzene
• CAS NO: 105655-17-2
• Molecular Formula: C₈H₇BrN₂O₄
• Molecular Weight: 275.05618
• Mol File: 105655-17-2.mol
• Article Data: 6

Chemical Properties

• Melting Point: 107-109℃
• Boiling Point: 408.5±40.0 °C(Predicted)
• Appearance: /
• Density: 1.744±0.06 g/cm3(Predicted)
• PKA: -4.79±0.25(Predicted)
• CAS DataBase Reference: Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate(105655-17-2)
• EPA Substance Registry System: Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate(105655-17-2)

Safety Data

• Hazardous Substances Data: 105655-17-2(Hazardous Substances Data)

Upstream product

• 556651-33-3 3-bromo-4-amino-5-nitro-benzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 1588-83-6 4-amino-3-nitrobenzoic acid 
• 3987-92-6 methyl 4-amino-3-nitrobenzoate 

Downstream Products

• 1245643-11-1 methyl 3,4-diamino-5-bromobenzoate 
• 790254-17-0 methyl 3-bromo-4-[(E/Z)-but-2-enyl(trifluoroacetyl)amino]-5-nitrobenzoate 
• 881909-48-4 methyl 3-bromo-4-[(E/Z)-but-2-enylamino]-5-nitrobenzoate 
• 881909-54-2 methyl 3-amino-5-bromo-4-[(E/Z)-but-2-enylamino]benzoate 
• 790254-22-7 methyl 7-amino-3-ethyl-1H-indole-5-carboxylate 
• 790254-16-9 methyl 3-bromo-5-nitro-4-[(trifluoroacetyl)amino]benzoate 

Relevant articles and documents

Synthesis of 3,5,7-substituted indoles via heck cyclisation

Traditional strategies in indole chemistry do not allow high yielding access to some substitution patterns such as 3,5,7-trisubstituted indoles. We report in this article the efficient synthesis of this type of indole. The Heck cyclisation strategy we use

P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN

The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.

TRICYCLIC INDOLE DERIVATIVES FOR USE IN THE TREATMENT OF ALZHEIMER’S DISEASE

The present invention relates to novel ketone compounds of formula (I) having Asp2 (β-secretase, BACE1 or Memapsin-2) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases chara